American Healthcare REIT, Inc. (NYSE:AHR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

American Healthcare REIT, Inc. (NYSE:AHR) has received an average recommendation of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $15.88.

A number of equities research analysts recently issued reports on AHR shares. Bank of America initiated coverage on shares of American Healthcare REIT in a report on Monday, March 4th. They issued a “buy” rating and a $15.00 price objective for the company. Citigroup began coverage on shares of American Healthcare REIT in a research report on Monday, March 4th. They issued a “neutral” rating and a $14.00 price target on the stock. Morgan Stanley started coverage on shares of American Healthcare REIT in a report on Monday, March 4th. They set an “overweight” rating and a $17.00 price objective for the company. JMP Securities reiterated a “market outperform” rating and issued a $16.00 target price on shares of American Healthcare REIT in a report on Monday, March 25th. Finally, Barclays initiated coverage on shares of American Healthcare REIT in a report on Thursday, March 14th. They set an “overweight” rating and a $18.00 price target for the company.

American Healthcare REIT Price Performance

Shares of NYSE AHR opened at $13.87 on Tuesday. The firm has a 50 day moving average price of $13.75. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.19 and a quick ratio of 0.19. American Healthcare REIT has a 52 week low of $12.63 and a 52 week high of $14.90.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 19th. Stockholders of record on Thursday, March 28th were issued a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.21%.

Insider Buying and Selling at American Healthcare REIT

In other news, Director Mathieu B. Streiff purchased 83,333 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was purchased at an average cost of $12.00 per share, with a total value of $999,996.00. Following the acquisition, the director now directly owns 90,740 shares of the company’s stock, valued at approximately $1,088,880. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Institutional Trading of American Healthcare REIT

Several large investors have recently made changes to their positions in the business. Peak Financial Advisors LLC bought a new stake in American Healthcare REIT during the 1st quarter worth about $416,000. Seven Grand Managers LLC acquired a new stake in shares of American Healthcare REIT in the first quarter valued at approximately $1,032,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in American Healthcare REIT during the 1st quarter worth $7,694,000. Peregrine Capital Management LLC bought a new position in American Healthcare REIT in the 1st quarter valued at $7,763,000. Finally, Principal Financial Group Inc. acquired a new stake in shares of American Healthcare REIT in the 1st quarter valued at $88,504,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.